Released May 17, 2012, after the close
10-Q filed May 17, 2012, 47 days after period end · 0001193805-12-000939
Q1 2012 · 10-Q
Revenue$4.54M$4.54M −23.6% vs Q1 2011−31.8% vs Q4 2011
Net Income-$670.98K-$670.98K N/M vs Q1 2011N/M vs Q4 2011
EPS Diluted-$0.05-$0.05 N/M vs Q1 2011no prior Q4 2011 on file
Gross Profit$1,587,231−34.6%
Operating Income$488,508N/M
Operating Cash Flow$508,675−53.9%
Free Cash Flowderived$315,042−64.7%
Margins · derived
Gross margin35.0%−5.9 pt vs Q1 2011
Operating margin10.8%+22.8 pt vs Q1 2011
Net margin-14.8%+19.3 pt vs Q1 2011
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $4.54M | $5.94M |
| Net Income | -$670.98K | -$2.02M |
| EPS Diluted | -$0.05 | -$0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Tanke Biosciences Corp · CIK 1452011 · Engraved from SEC EDGAR